Castle Biosciences Inc Forecast, price target & analysts
Castle Biosciences Inc Target price 2026 - Analyst rating & recommendation
Castle Biosciences Inc Classifications & Recommendation
Castle Biosciences Inc Price Target
| Target Price | $44.88 |
| Price | $35.81 |
| Potential |
25.33%
register free of charge
|
| Number of Estimates | 11 |
|
11 Analysts have issued a price target Castle Biosciences Inc 2027 .
The average Castle Biosciences Inc target price is $44.88.
This is
25.33%
register free of charge
$59.85
67.13%
register free of charge
$35.35
1.28%
register free of charge
|
|
| A rating was issued by 15 analysts: 14 Analysts recommend Castle Biosciences Inc to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Castle Biosciences Inc stock has an average upside potential 2027 of
25.33%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 344.23 | 380.24 |
| 3.66% | 10.46% | |
| EBITDA Margin | -1.73% | 2.90% |
| 126.47% | 267.49% | |
| Net Margin | -7.02% | -10.63% |
| 227.71% | 51.46% |
11 Analysts have issued a sales forecast Castle Biosciences Inc 2026 . The average Castle Biosciences Inc sales estimate is
This results in the following potential growth metrics:
9 Analysts have issued an Castle Biosciences Inc EBITDA forecast 2026. The average Castle Biosciences Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
11 Castle Biosciences Inc Analysts have issued a net profit forecast 2026. The average Castle Biosciences Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.83 | -1.32 |
| 233.87% | 59.04% | |
| P/E | negative | |
| EV/Sales | 2.20 |
11 Analysts have issued a Castle Biosciences Inc forecast for earnings per share. The average Castle Biosciences Inc EPS is
This results in the following potential growth metrics and future valuations:
Castle Biosciences Inc...
Current Castle Biosciences Inc Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BTIG |
Locked
➜
Locked
|
Locked | Aug 03 2026 |
| Roth Capital |
Locked
➜
Locked
|
Locked | Jun 25 2026 |
| BTIG |
Locked
➜
Locked
|
Locked | May 13 2026 |
| Baird |
Locked
➜
Locked
|
Locked | May 07 2026 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Apr 20 2026 |
| Baird |
Locked
➜
Locked
|
Locked | Feb 27 2026 |
| Guggenheim |
Locked
➜
Locked
|
Locked | Jan 26 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
BTIG:
Locked
➜
Locked
|
Aug 03 2026 |
|
Locked
Roth Capital:
Locked
➜
Locked
|
Jun 25 2026 |
|
Locked
BTIG:
Locked
➜
Locked
|
May 13 2026 |
|
Locked
Baird:
Locked
➜
Locked
|
May 07 2026 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Apr 20 2026 |
|
Locked
Baird:
Locked
➜
Locked
|
Feb 27 2026 |
|
Locked
Guggenheim:
Locked
➜
Locked
|
Jan 26 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
